Results 231 to 240 of about 106,545 (283)

Irreversible Imatinib-induced Pneumonitis following Long-term Imatinib Administration

Internal Medicine, 2007
Tetsuya Mine, Takashi Seto, Kenji Eguchi, Nobuhiko Seki, Akemi Ito, Kennichi Watanabe, Kazutsugu Uematsu, Reishi Shibakuki   +7 more
openaire   +4 more sources

Imatinib [PDF]

Reactions Weekly, 2020
openaire   +1 more source

A single-cell spatial chart of the airway wall reveals proinflammatory cellular ecosystems and their interactions in health and asthma. [PDF]

Nat Immunol
Joulia R, Patti S, Traves WJ, Loewenthal L, Yates L, Walker SA, Puttur F, Al-Sahaf M, Cahill KN, Lai J, Siddiqui S, Boyce JA, Israel E, Lloyd CM.   +13 more
europepmc   +1 more source

Imatinib induced lichen planus

Indian Journal of Dermatology, 2011
S Anandan, R Sudha, K Krishnarathnam, TP Vetrichevvel   +3 more
openaire   +4 more sources

Structure and Dynamics of the ABL1 Tyrosine Kinase and Its Important Role in Chronic Myeloid Leukemia. [PDF]

Arch Pharm (Weinheim)
Irgit A, Kamıs R, Sever B, Tuyun AF, Otsuka M, Fujita M, Demirci H, Ciftci H.   +7 more
europepmc   +1 more source

US intergroup study of chemotherapy plus dasatinib and allogeneic stem cell transplant in Philadelphia chromosome positive ALL [PDF]

, 2016
Uy, Geoffrey L.
core   +1 more source

Precision Medicine in Oncology: Imatinib Dosing in the Obese Cancer Population Using Virtual Clinical Trials. [PDF]

CPT Pharmacometrics Syst Pharmacol
Burhanuddin K, Mohammed A, Burhanuddin NA, Badhan RKS.   +3 more
europepmc   +1 more source

Preclinical study of microphthalmia-associated transcription factor inhibitor ML329 in gastrointestinal stromal tumor growth. [PDF]

Mol Ther Oncol
Guerrero M, Proaño-Pérez E, Serrano-Candelas E, García-Valverde A, Carrillo-Rodríguez B, Rosell J, Serrano C, Martin M.   +7 more
europepmc   +1 more source

Quality-Adjusted Time Without Symptoms of Disease or Toxicity (Q-TWiST) in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Comparison of Ponatinib Versus Imatinib. [PDF]

Cancer Med
Ashaye A, Shi L, Aldoss I, Montesinos P, Vachhani P, Rocha V, Papayannidis C, Leonard JT, Baer MR, Ribera JM, McCloskey J, Wang J, Rane D, Guo S.   +13 more
europepmc   +1 more source

Survival outcome and impact of delayed imatinib therapy in gastric gastrointestinal stromal tumors. [PDF]

Front Surg
Jansuwan R, Samphao S, Chaochankit W.
europepmc   +1 more source